Arcutis Biotherapeutics Inc (ARQT)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
14.62 -0.19 (-1.28%) 03/14/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 14.65 +0.03 (+0.21%) 17:30 ET
for Fri, Mar 14th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Operating Expenses | 65,827 | 62,628 | 71,286 | 57,078 | 42,080 |
| Operating Income | -65,827 | -62,628 | -71,286 | -57,078 | -42,080 |
| Interest Expense | 2,000 | 1,838 | 0 | 0 | 0 |
| Other Income | 421 | 142 | -40 | 98 | 72 |
| Pre-tax Income | -67,406 | -64,324 | -71,326 | -56,980 | -42,008 |
| Net Income Continuous | -67,406 | -64,324 | -71,326 | -56,980 | -42,008 |
| Net Income | $-67,406 | $-64,324 | $-71,326 | $-56,980 | $-42,008 |
| EPS Basic Total Ops | -1.31 | -1.27 | -1.44 | -1.14 | -0.84 |
| EPS Basic Continuous Ops | -1.31 | -1.27 | -1.44 | -1.14 | -0.84 |
| EPS Diluted Total Ops | -1.31 | -1.27 | -1.44 | -1.14 | -0.84 |
| EPS Diluted Continuous Ops | -1.31 | -1.27 | -1.44 | -1.14 | -0.84 |
| EBITDA(a) | $-65,400 | $-61,860 | $-70,265 | $-55,808 | $-41,177 |